PRICE / VOLUME SPIKE EXPECTED MONDAY am. Earlybird SpecialTrade...Aftermarket Newsflash!

SOME 
      THINGS NEVER CHANGE,
      
      THE 
      EARLY BIRD STILL CATCHES THE WORM! 
      
      12 to 20 Plus, Inc. (OTC BB: TTTP) Announces $10 
      million Cash Equity Line…
              
           Cash is still 
      king!
      
Friday 
      was a slow news day bereft of the typical Wall Street chatter, and volume 
      normally associated with an open market. Unfortunately, the markets were 
      closed to pay respects to Ronald Wilson Reagan, the 40th President of the 
      United States. However, we are still here at work scouring the wire for 
      other below radar opportunities particularly in the micro cap realm. We 
      tend to look for smaller companies that have a viable business and 
      products already in the pipeline.  
      We think we’ve found one! One of our criteria is to see a company 
      we have tracked and like, suddenly receive a meaningful infusion of cash, 
      a launch catalyst. We believe the company we are about to introduce to 
      you, is a company, that investors will be scrambling to own early Monday 
      morning, as they wake-up to their monitors and catch the news “TTTP 
      receives $10 million cash equity line” and a distribution channel is also 
      being negotiated as we speak, another launch 
      catalyst!

      
Fridays 
      HUSH-HUSH market will enable the benefactors of this new bulletin to Catch 
      an Early Bird Special Trade on this NEWS FLASH that previously wasn’t 
      tradable because of a closed market at time of news release. Look for a 
      PRICE VOLUME SPIKE early Monday a.m. for: (OTC BB: TTTP) the Early Bird 
      Catches the Worm!

      
        
        

          
            
 AFTERMARKET 
            PRESS RELEASE                                                                                           Thursday 
            10, 2004

          
            
 

      
12 to 
      20 Plus, Inc., Today announced that it has reached an Agreement for a $10 
      Million Cash Equity Line
Thursday June 10, 6:06 pm 
      ET 
      

      
SAN LUIS OBISPO, Calif., June 
      10, 2004 (PRIMEZONE) -- 12 To 20 Plus, Inc (OTC BB:TTTP.OB - News), a leading research-based nutraceutical 
      company and a pioneer in the emerging field of specialized nutritional 
      formulas and nutraceuticals, announced today that it has reached an 
      agreement and signed a $10 million cash equity line. 

      
Under the terms of the 
      agreement, TTTP may elect to receive as much as $10 million in common 
      stock purchases over the next three years. 

      
Carol Slavin, President of 12 
      To 20 Plus said, ``We have been very diligent in our research of potential 
      funding sources. We intend to use the funds to grow revenues by 
      significantly expanding our manufacturing capabilities and marketing 
      efforts. The current opportunities for growth and development are greater 
      now than ever.'' 

      
The company is currently in 
      negotiations with Banyan Corporation's wholly owned subsidiary 
      ChiropraticUSA, a publicly traded company (OTC BB:BANY.OB - News), to become the premier distributor of 12 to 
      20 Plus' proprietary full line of ``over the counter'' nutritional 
      formulas and nutraceutical wellness supplements to the chiropractic 
      industry through ChiropraticUSA's Franchised chiropractic clinics across 
      North America.

      
``We are extremely excited, 
      if not overwhelmed, about 12 to 20 Plus' Wellness Supplements as they are 
      exactly what we have been looking for to incorporate within our franchised 
      clinics as an additional revenue stream'' stated Michael Gelmon, CEO of 
      Banyan Corporation. Additionally, Gelmon stated that ChiropracticUSA is 
      becoming the dominant face within the chiropractic industry: ``We believe 
      that upon completion of our due diligence process, we will, in fact, be a 
      major national distributor of 12 to 20 Plus's exclusive and proprietary 
      product lines as there are more than 50,000 Chiropractic Clinics that 
      Banyan maintains its presence within.''

      
Carol Slavin also stated: 
      ``With this distribution channel in place, our sales will immediately and 
      dramatically increase. The company will initiate a massive marketing 
      campaign to all 50,000 Chiropractic Clinics within the United States 
      through Banyan Corporation's ChiropracticUSA marketing department. We are 
      extremely excited to team up with ChiropracticUSA.'' 

      
About 12 to 20 Plus, 
      Incorporated - http://www.12to20plus.com 

      
12 to 20 Plus, Incorporated 
      is a research-based nutraceutical company and a pioneer in the emerging 
      field of specialized nutritional formulas and nutraceuticals. One of the 
      company's flagship products, the Zit Stick(r), is part of a ``spa style'' 
      acne therapy system. The market for acne remedies is expected to reach 
      $370 million in 2004. 

      
12 to 20 Plus, Inc. also 
      markets highly effective condition-specific dietary supplements through 
      its Nutraceutical Research Group (NRG) division. These products, 
      manufactured by FDA-approved labs, contain the most sophisticated 
      combination of extensively researched nutritional elements available. 
      Instead of herbs, the Company utilizes potent pharmaceutical grade ``amino 
      acids'', important protein constituents that serve as neurotransmitter 
      precursors, membrane stabilizers and enzyme precursors. Some of the 
      proprietary NRG products include: Anaplex (tm), an antidepressant drug 
      alternative; VisionKare(tm), an advanced supplement for macular 
      degeneration; ChemoKare(tm), a unique combination of extracts designed to 
      treat the side effects of chemotherapy; QuitSystem(r), a neuronutrient 
      supplementation for recovery from alcohol, drugs and smoking; Hinoki 
      Bana(tm), a treatment for men and women with hair loss problems. Retail 
      sales in the explosive dietary supplement market are expected to hit $40 
      billion by year 2007, according to Frost & Sullivan reports. 
      

      
About Banyan 
      Corporation - http://www.banyancorp.com 

      
http://www.chiropracticusa.net 
      

      
Banyan Corporation is a 
      publicly traded holding company focused on investing in and building a 
      network of operating subsidiaries engaged in various innovative 
      businesses. Currently the company's subsidiary, Chiropractic USA, Inc., is 
      focusing on the development of branded chiropractic clinics throughout 
      North America by way of acquisitions of existing clinics as well as 
      franchising chiropractic clinics under its marks and uniform operating 
      systems and practices. The company's other subsidiary; Banyan Financial 
      Services, Inc., is providing practice finance solutions to the 
      chiropractic, medical, dental and healthcare communities. 
      

      
The Private Securities 
      Litigation Reform Act of 1995 provides a ``safe harbor'' for 
      forward-looking statements. Certain information included in this press 
      release (as well as information included in oral statements or other 
      written statements made or to be made by Banyan Corporation) contains 
      statements that are forward-looking, such as statements relating to the 
      future anticipated direction of the high technology industry, plans for 
      future expansion, various business development activities, planned capital 
      expenditures, future funding sources, anticipated sales growth and 
      potential contracts. Such forward-looking information involves important 
      risks and uncertainties that could significantly affect anticipated 
      results in the future and, accordingly, such results may differ from those 
      expressed in any forward-looking statements made by or on behalf of Banyan 
      Corporation. These risks and uncertainties include, but are not limited 
      to, those relating to development and expansion activities, dependence on 
      existing management, financing activities, domestic and global economic 
      conditions, changes in federal or state tax laws, and market competition 
      factors. For a description of additional risks and uncertainties, please 
      refer to Banyan's filings with the Securities and Exchange Commission. 
      

      
Disclaimer: Micro Cap 
      Penny Picker  IS NOT an 
      Investment banker, Stockbroker, Broker Dealer, Financial Analyst, or a 
      professional financial advisor of any kind. This Report is for 
      informational purposes only and should not be construed as an offer to buy 
      or sell any securities at all . The Information provided in this document 
      has been provided to Micro Cap Penny Picker  by sources believed to be reliable 
      but cannot guarantee its accuracy. Some information comes from SEC 
      filings, Websites, and other “already public information” about the 
      company. Please do your own Due diligence before investing in any company 
      profiled within Micro Cap Penny Picker  reports. The Micro Cap Penny 
      Picker has been paid $10,000.00 cash for the distribution of this report 
      by a non affiliated third party.

      

     

  

    

  

    

  

    
      
© Copyright 2004 Micro Cap 
      Penny Picker. All Rights 
Reserved

 

TRADEWAY COMMUNICATIONS LLC · Ste 132 103-2609 Westview Dr. · Noorth Vancouver, BC. Canada V7N7N2